期刊文献+

RUNX1表观遗传机制在白血病发生中的作用研究进展 被引量:4

Epigenetic Mechanism of RUNX1 in Pathogenesis of Leukemia——Review
下载PDF
导出
摘要 RUNX1又称为AML1,是RUNX转录因子蛋白家族中的成员之一,是白血病染色体易位最常见的靶位点。RUNX1是十分重要的转录因子,可双向(促进或抑制)调节造血相关基因的表达。RUNX1蛋白可接受多种翻译后修饰,其活性可受这些翻译后修饰的影响,从而调节造血细胞的分化、凋亡及自我更新。本文重点综述RUNX1的靶基因、转录机制及翻译后修饰等表观遗传机制在白血病发生中的作用。 RUNX1, also called AML1, is a member of RUNX transcriptional factor family, and also is the most frequent target for chromosomal translocations in leukemia. RUNX1 is a very important transcription factor, can enhance or repress the expressions of many hematopoiesis related genes. RUNX1 may recieve a series of post-translational modifications, and the activity of RUNX1 can be affected by these post-translational modifications, thus RUNX1 regulates the differentiation, apoptosis and self-renewal of hematopoiestic cells. This article reviews the role of RUNX1 in the pathogenesis of leukemia mainly including its target genes, transcriptional mechanism and post-translational modifications.
作者 张寒 郑胡镛
出处 《中国实验血液学杂志》 CAS CSCD 2010年第2期525-530,共6页 Journal of Experimental Hematology
基金 国家高技术研究发展计划(863计划)现代医学技术专题项目 编号2006AA02ZAZ2
关键词 RUNX1 白血病 转录因子 翻译后修饰 RUNX1 leukemia transcriptional factor post-translational modification
  • 相关文献

参考文献32

  • 1Yamagata T, Maki K, Mitani K. Runxl/AML1 in normal and abnormal hematopoiesis. Int J Hematol, 2005 ; 82 ( 1 ) : 1 - 8. 被引量:1
  • 2De Braekeleer E, F6rec C, De Braekeleer M. RUNXI translocations in malignant hemopathies. Anticancer Res, 2009; 29 (4) : 1031 - 1037. 被引量:1
  • 3Kurokawa M, Hirai H. Role of AML1/Runxl in the pathogenesis of hematological malignancies. Cancer Sci, 2003 ; 94(10) : 841 - 846. 被引量:1
  • 4Miyoshi H, Shimizu K, Kozu T, et al. t(8;21 ) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA, 1991 ; 88(23) : 10431 - 10434. 被引量:1
  • 5Reed-Inderbitzin E, Moreno-Miralles I, Vanden-Eynden SK, et al.RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription. Oncogene ,2006 ; 25 (42) : 5777 - 5786. 被引量:1
  • 6Liu X, Zhang Q, Zhang DE, et al. Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis. Leukemia, 2009 ; 23 (4) : 739 - 745. 被引量:1
  • 7Mertz JA, Kobayashi R, Dudley JP. ALY is a common coacfivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer. J Virol, 2007; 81(7): 3503-3513. 被引量:1
  • 8Liu J, Park ES, Jo M. Runt-related transcription factor 1 regulates luteinized hormone-induced prostaglandin-endoperoxide synthase 2 ( Ptgs2 ) expression in rat periovulatory granulosa cells. Endocrinology, 2009 ; 150 (7) : 3291 - 3300. 被引量:1
  • 9Zhang HY, Jin L, Stilling GA, et al. RUNX1 and RUNX2 upregulated Galectin-3 expression in human pituitary tumors. Endocrine, 2009; 35(1) : 101 -111. 被引量:1
  • 10Wotton S, Terry A, Kilbey A, et al. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene, 2008; 27(44): 5856-5866. 被引量:1

二级参考文献22

共引文献10

同被引文献32

  • 1蔡晓辉,陈梅玉,晁红颖,姜乃可,卢绪章,韩文敏,秦伟,贾祝霞.骨髓增生异常综合症患者RUNX1基因突变分析[J].中国实验血液学杂志,2020,28(1):202-208. 被引量:8
  • 2Rao SA, Santosh V, Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma[J]. Mod Pathol, 2010, 23(10): 1404-1417. 被引量:1
  • 3Zhu LH, Liu T, Tang H, et al. MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor[J]. FEBS J, 2010, 277(18):3726-3734. 被引量:1
  • 4Feng J, Iwama A, Satake M, et al. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post- transcriptionally downregulating Runxl[J]. Br J Haematol, 2009, 145(3):412-423. 被引量:1
  • 5MROZEK K, MARCUCCI G, PASCHKA P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics:are we ready for a prognostically priori- tized molecular classification? [J]. Blood, 2007, 109: 431 -448. 被引量:1
  • 6MCDEVITT M A. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignan- cies[J]. Semin Oncol, 2012,39 : 109-122. 被引量:1
  • 7HOU H A,KUO Y Y,LIU C Y,et al. DNMT3A mu- tations in acute myeloid leukemia:stability during dis- ease evolution and clinical implications [J] Blood, 2012,119:559-568. 被引量:1
  • 8LEY T J,DING L, WALTER M J,et al. DNMT3A mutations in acute myeloid leukemia [J]. N Engl J Med, 2010,363 : 2424 - 2483. 被引量:1
  • 9LAROCHELLE O, BERTOLI S, VERGEZ F, et al. Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin?[J]. Oncotarget, 2011,2 : 850 - 861. 被引量:1
  • 10PATEL J P, GONEN M, FIGUEROA M E, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia[J]. N Engl J Med,2012,366: 1079-1089. 被引量:1

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部